Thermo Fisher Scientific is a global science and diagnostics company serving pharmaceutical, biotechnology, healthcare, academic, and government customers. It is known for instruments, chemicals, and ...

Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ETCompany ParticipantsAntonio Filosa - CEO, COO of North America ...

Q4 2025 Management View John Edward Adent, President and CEO, began the call by confirming his upcoming departure and the appointment of Mike as his successor, stating his commitment to a seamless ...

Q2 2025 Management View Paul Jeffrey Taubman, Chairman and CEO, opened with a reflection on recent events in Midtown Manhattan before highlighting that "we reported record-setting results as revenues, ...

Alkermes (ALKS) reports strong Q2 2025 results with 14% growth, robust finances, and positive Phase II narcolepsy data.

Key Points - Net income for the quarter ended June 30, 2025, rose 9.0% compared to the same period last year, with GAAP earnings per share increased from $0.67 to $0.73 in Q4 FY2025. Net interest ...

Key Points - Revenue (GAAP) rose to $17.2 million, surpassing analyst expectations by 5.5% and grew 14.2% year over year. AVISE CTD test volume increased 14% sequentially, and the ...